Categories Covered:Providing Quality HIV Care, HIV Care and Services Outside the US, HIV Prevention Methods, Adverse Events, Comorbidities, and HIV, HIV Treatment Strategies, Pregnancy, Childbirth, and HIV, HIV Epidemiology, HIV Testing, HIV Education and Risk Management, HIV Treatments in Development, HIV, Discrimination, and Law, First-Line HIV Treatment, Managing People Newly Diagnosed With HIV, HIV Care Continuum, HIV Policy and Advocacy, Managing HIV Drug Resistance
The prevalence of advanced HIV among people beginning antiretroviral treatment has declined in eight of 10 resource-constrained countries surveyed, while median immune cell counts went up.
The first study of hepatitis C incidence and injecting behavior across cities and over 25 years showed the differences in incidence reflect differences in policies to reduce the harm of injecting drug use.
New rapid response of HIV care and prevention measures reached an estimated 88 percent of people injecting drugs in Athens, Greece within the year that followed the initiation of the services.
Technology that eliminates daily pill taking, and with it "pill fatigue," stigma and other barriers to adherence, has already proven its value, and is on the horizon for HIV.
The prospect of a coming explosion of teenagers, across countries that are struggling now to control the spread and impacts of HIV, is daunting.
The numbers of people who are receiving antiretroviral treatment HIV in remote rural areas of west and central Africa for whom that treatment is succeeding is about half of what it needs to be.
Four of seven sub-Saharan African countries followed by researchers over the last year and a half now can track the effectiveness of HIV treatment among all patients receiving it.
The World Health Organization has released guidelines to help nations and programs use self-testing for HIV as an additional tool to increase the numbers of people who know if they are infected with the virus.
By the time the vast majority of people who have HIV reach testing and treatment for the virus, they have had it long enough that they are vulnerable to deadly fungal infections.
Kenya's medical circumcision program launched early with ambition, charting circumcisions performed for 1.3 million men by the end of 2015, leaving evaluators asking what is and what will be the impact of this HIV prevention intervention on the epide...